CG
RPRX icon

Cutler Group’s Royalty Pharma RPRX Stock Holding History

Cutler Group’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-440
Closed -$17.1K – 5947
2021
Q3 		$15K Sell
440
-10,561
-96% -$410K ﹤0.01% 3608
2021
Q2 		$450K Buy
11,001
+3,048
+38% +$130K 0.02% 809
2021
Q1 		$346K Buy
+7,953
New +$377K 0.02% 926
2020
Q4 		– Sell
-388
Closed -$16.5K – 5396
2020
Q3 		$16K Buy
+388
New +$16.6K ﹤0.01% 2655

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
SGA
Siguler Guff Advisers New York $56.1M AUM 46.63% 1-Year Est. Return

Cutler Group's RPRX Position: Q4 2021 in Review

Cutler Group sold out of Royalty Pharma (RPRX) in Q4 2021, closing a stake of 440 shares — an estimated $17.1K sold.

Cutler Group first reported a position in RPRX in Q3 2020 and held it in 4 quarters. The position peaked at $450K in Q2 2021. 266 funds tracked by Wall St. Rank hold RPRX as of Q4 2021.

  • Cutler Group reported no remaining Royalty Pharma position as of Q4 2021 after selling out during the quarter.
  • Cutler Group sold 440 Royalty Pharma shares in Q4 2021, an estimated $17.1K.
  • Cutler Group first reported a position in Royalty Pharma in Q3 2020 and held it in 4 quarters.
  • Cutler Group's Royalty Pharma position peaked at $450K in Q2 2021.
  • 266 funds tracked by Wall St. Rank held Royalty Pharma as of Q4 2021.

Based on Cutler Group's 13F filing for Q4 2021, filed 18 Jan 2022.